TOX3 overexpression activates the gluconeogenic program, resulting in hyperglycemia and insulin resistance in mice and hepatocyte-specific TOX3 knockout suppresses gluconeogenesis through FOXO1 [43]. Here, FOXO1 is linked to Hyperglycemia.